Four investigations into the peptide research record
Measurable facts about the peptide research literature and the public record around it, with the dataset behind every figure.
Three of the four pieces below examine this portfolio's own corpus, which is stated on every page rather than left for a reader to notice. A publication that measures other people's work and not its own is doing rhetoric, not measurement.
-
12 rows out of 188,556
The 77 compound queries returned 404,706 records between them. The corpus carries 902, which is 0.22% of the pooled result.
-
30 of 77 carry no human-trial record
Across 77 compounds: 23 human-trial, 16 limited-human, 24 animal and in vitro only, 13 preparation or mixture, and 1 whose records state no model.
-
5 flagged titles in 902
5 of 902 titles were flagged as reporting an absent, failed or negative effect: 0.55%, on 5 of 77 compounds.
-
673 hits, 431 documents
On 13 October 2026: "compounded drug" 124, 503A 283, "outsourcing facility" 136, "bulk drug substances" 130.
How this publication counts
Every figure on this site is generated by a script in the open, from files a reader can download. Every piece states what was counted, from which files, on what date and with what query, and every piece states what the analysis cannot show. No full texts were read, so nothing here is a claim about what any study concluded.
The rules are written down once on the methods page, and the 77 compounds behind three of the four pieces are the corpus this portfolio publishes from.